EMEA-001016-PIP01-10-M01
Key facts
Active substance |
Chemically modified extract of grass pollen from Holcus lanatus, Phleum pratense and Poa pratensis
|
Therapeutic area |
Pneumology-allergology
|
Decision number |
P/0084/2019
|
PIP number |
EMEA-001016-PIP01-10-M01
|
Pharmaceutical form(s) |
Coated tablet
|
Condition(s) / indication(s) |
Treatment of allergic rhinitis / rhino-conjunctivitis
|
Route(s) of administration |
Sublingual use
|
Contact for public enquiries |
Lofarma S.p.A.
|
Decision type |
RPM: decision refers to a refusal on the application for modification of an agreed PIP
|